Status:
COMPLETED
Point of Care Tests for Syphilis and HIV
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Alberta Health services
Conditions:
Syphilis
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
This study will evaluate the performance of two point-of-care dual syphilis and HIV tests \[Multiplo TP/HIV test (MedMira Inc, Halifax, Nova Scotia) and the INSTI Multiplex HIV-1/HIV-2/Syphilis Antibo...
Detailed Description
Purpose: In the context of resurgent syphilis in Alberta (Canada), the investigators will evaluate the performance of two dual HIV/syphilis POCT. Their utility in the point of care treatment for syph...
Eligibility Criteria
Inclusion
- Individuals who would routinely be screened for syphilis and HIV
Exclusion
- \< 16 years, unable to provide signed informed consent
Key Trial Info
Start Date :
July 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 14 2022
Estimated Enrollment :
1526 Patients enrolled
Trial Details
Trial ID
NCT04514848
Start Date
July 27 2020
End Date
February 14 2022
Last Update
December 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ameeta Singh
Edmonton, Alberta, Canada, T6J2C2